1. mdmx is a negative regulator of p53 activity in vivo.
- Author
-
Finch RA, Donoviel DB, Potter D, Shi M, Fan A, Freed DD, Wang CY, Zambrowicz BP, Ramirez-Solis R, Sands AT, and Zhang N
- Subjects
- Animals, Apoptosis physiology, Cell Division physiology, Cells, Cultured, Embryo, Mammalian, Fibroblasts cytology, Fibroblasts physiology, Mice, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins c-mdm2, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Nuclear Proteins, Proto-Oncogene Proteins physiology, Tumor Suppressor Protein p53 physiology
- Abstract
Regulation of p53 protein activity is required for normal embryogenesis, tumor suppression, and cellular response to DNA damage. Here we report that loss of mdmx, a p53-binding protein, results in midgestational embryo lethality, a phenotype that is completely rescued by the absence of p53. Mice homozygous for both mdmx and p53 null mutations are viable and appear developmentally normal. Fibroblasts derived from embryos with reduced mdmx expression demonstrate a decreased growth rate and increased UV-induced apoptosis compared with wild-type cells and contain elevated levels of p53 and several p53 target proteins including the proapoptotic bax protein. These observations demonstrate that mdmx functions as a critical negative regulator of p53 in vivo.
- Published
- 2002